Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Annals of Hematology|September 14, 2000
Intercellular adhesion molecular 1 on monocytes mediates adhesion as well as trans-endothelial migration and can be downregulated using antisense oligonucleotidesU Steidl, R Haas, R KronenwettBlood|February 3, 1998
Oligodeoxyribonucleotide uptake in primary human hematopoietic cells is enhanced by cationic lipids and depends on the hematopoietic cell subsetR Kronenwett, U Steidl, M Kirsch, et al.Nucleic Acids Research|October 28, 1999
A theoretical approach to select effective antisense oligodeoxyribonucleotides at high statistical probabilityV Patzel, U Steidl, R Kronenwett, et al.Leukemia|October 27, 2015
Thrombocytopenia in MDS: epidemiology, mechanisms, clinical consequences and novel therapeutic strategiesW Li, K Morrone, S Kambhampati, et al.Oncogene|December 17, 2013
Stem cell origin of myelodysplastic syndromesH K Elias, C Schinke, S Bhattacharyya, et al.Bone Marrow Transplantation|April 12, 2005
Cyclosporine A and mycophenolate mofetil vs cyclosporine A and methotrexate for graft-versus-host disease prophylaxis after stem cell transplantation from HLA-identical siblingsF Neumann, T Graef, C Tapprich, et al.Cancer Gene Therapy|January 20, 2007
The proteasome inhibitor bortezomib acts differently in combination with p53 gene transfer or cytotoxic chemotherapy on NSCLC cellsJ Neukirchen, A Meier, A Rohrbeck, et al.British Journal of Haematology|August 16, 2005
High-dose idarubicin, cyclophosphamide and melphalan as conditioning for autologous stem cell transplantation increases treatment-related mortality in patients with multiple myeloma: results of a randomised studyR Fenk, P Schneider, M Kropff, et al.Oncogene|October 15, 2013
Aggressive acute myeloid leukemia in PU.1/p53 double-mutant miceP Basova, V Pospisil, F Savvulidi, et al.Bone Marrow Transplantation|November 9, 2004
Successful transplantation of peripheral blood stem cells mobilized by chemotherapy and a single dose of pegylated G-CSF in patients with multiple myelomaU Steidl, R Fenk, I Bruns, et al.Pageof 2